Clinical trial Recruiting at 5 sites Observational Ages 18 and up

Follow-up on outcomes after surgery with the LISA implant for back pain

Official title: LISA Post Market Clinical Follow-Up Study:Post Marketing Prospective Documentation of Clinical Outcomes (Post-operative, Safety and Performance) After Lumbar Dynamic Stabilization Surgery With LISA Implant

Run by Backbone · NCT04631133 · Data updated 2026-11-12

This study looks at how well the LISA implant works and its safety for people who have had surgery for chronic low-back pain.

More Chronic Low-back Pain trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment136 (estimated)
SponsorBackbone
Industry-sponsored
Locations5 sites (Silkeborg and 4 other locations)
StatusRecruiting
StartedApril 17, 2019
Main results expectedDecember 31, 2024
Study endsDecember 31, 2028
Registry record updatedJuly 21, 2022
Trial IDNCT04631133 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are skeletally mature adults aged 18 and older who have chronic low-back pain due to degenerative lesions and have not found relief from conservative treatments.

Probably not a fit

Patients with advanced degenerative disk lesions, spondylolisthesis, osteoporosis, or other specified exclusions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study monitors the clinical outcomes of patients who have undergone surgery using the Lumbar Implant for Stiffness Augmentation (LISA) to treat chronic low-back pain associated with degenerative lesions. The LISA device, which has already received CE certification, consists of a PEEK interspinous spacer, a polyester band, and a titanium blocker, designed to stabilize the spine. The study aims to evaluate the long-term safety and performance of the LISA implant in a real-world setting following its market introduction.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the effectiveness and safety of the LISA implant, potentially improving treatment options for patients with chronic low-back pain.

How similar studies have gone: Other post-market studies of similar spinal implants have shown promising results, indicating that this approach is supported by prior successful evaluations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Skeletally mature patients Patient ≥18 years of age
* Patients with low-back pain caused by degenerative lesions of grade II, III and IV (Pfirrmann MRI classification)
* Failed conservative treatment for low back pain conducted for at least 6 months

Exclusion Criteria:

* Stage V degenerative disk lesions in Pfirrmann's MRI classification
* Spondylolisthesis
* Osteoporosis
* Non-specific back pain
* Modic 2 and Modic 3 changes
* L5/S1 segments affected
* Local or general infections that may compromise the surgical goals
* Major local inflammatory phenomena
* Pregnant and lactating Women
* Immunosuppressive diseases
* Bone immaturity
* Severe mental illnesses
* Bone metabolism diseases that may compromise the mechanical support expected from this type of implant
* Patient with worker's compensation, under litigation or on disability benefits
* Excessive physical activities
* Patients deprived of their liberty in accordance with respective national regulations
* Protected patients or patients not in a position to declare his or her consent in accordance with respective national regulations

Where it's running

  • Elective Surgery Center, Silkeborg Regional Hospital
    Silkeborg, Denmark
    Recruiting
  • Pellegrin University Hospital Center
    Bordeaux, France
    Recruiting
  • Saint-Charles Clinic
    Lyon, France
    Recruiting
  • Pitié-Salpêtrière University Hospital Center
    Paris, France
    Recruiting
  • Asklepios Stadtklinik, Bad Wildungen
    Bad Wildungen, Germany
    Recruiting

Study contacts

  • Principal investigator: Vincent Pointillart — Pellegrin University Hospital Center
  • Study coordinator: Aurélie Affret
  • Email: aat@backbone.pro
  • Phone: 0033686114973

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.